PL3630806T3 - Analogi peptydów gip o długotrwałym działaniu - Google Patents

Analogi peptydów gip o długotrwałym działaniu

Info

Publication number
PL3630806T3
PL3630806T3 PL18728872.5T PL18728872T PL3630806T3 PL 3630806 T3 PL3630806 T3 PL 3630806T3 PL 18728872 T PL18728872 T PL 18728872T PL 3630806 T3 PL3630806 T3 PL 3630806T3
Authority
PL
Poland
Prior art keywords
long
peptide analogues
gip peptide
acting
acting gip
Prior art date
Application number
PL18728872.5T
Other languages
English (en)
Inventor
Mette Marie Rosenkilde
Jens Juul Holst
Lærke Smidt GASBJERG
Alexander Hovard SPARRE-ULRICH
Maria Buur Nordskov Gabe
Original Assignee
The University Of Copenhagen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The University Of Copenhagen filed Critical The University Of Copenhagen
Publication of PL3630806T3 publication Critical patent/PL3630806T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
PL18728872.5T 2017-05-31 2018-05-31 Analogi peptydów gip o długotrwałym działaniu PL3630806T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17173628 2017-05-31
PCT/EP2018/064355 WO2018220123A1 (en) 2017-05-31 2018-05-31 Long-acting gip peptide analogues

Publications (1)

Publication Number Publication Date
PL3630806T3 true PL3630806T3 (pl) 2024-05-13

Family

ID=59021262

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18728872.5T PL3630806T3 (pl) 2017-05-31 2018-05-31 Analogi peptydów gip o długotrwałym działaniu

Country Status (11)

Country Link
US (1) US11572399B2 (pl)
EP (2) EP3630806B1 (pl)
JP (1) JP2020521784A (pl)
KR (1) KR20200014287A (pl)
CN (1) CN110691788B (pl)
AU (1) AU2018276434B2 (pl)
BR (1) BR112019025195A8 (pl)
CA (1) CA3064510A1 (pl)
ES (1) ES2972848T3 (pl)
PL (1) PL3630806T3 (pl)
WO (1) WO2018220123A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3189072B1 (en) 2014-09-05 2018-07-18 University of Copenhagen Gip peptide analogues
CA3064510A1 (en) 2017-05-31 2018-12-06 University Of Copenhagen Long-acting gip peptide analogues
RU2020136305A (ru) * 2018-05-04 2022-05-05 Ново Нордиск А/С Производные gip и пути их применения
EP3891174A1 (en) * 2018-12-03 2021-10-13 Antag Therapeutics ApS Modified gip peptide analogues
WO2023139106A2 (en) 2022-01-18 2023-07-27 Novo Nordisk A/S Long-acting gipr antagonists

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869602A (en) 1995-03-17 1999-02-09 Novo Nordisk A/S Peptide derivatives
JP3149958B2 (ja) 1996-08-30 2001-03-26 ノボ ノルディスク アクティーゼルスカブ Ｇｌｐ―１誘導体
US6458924B2 (en) 1996-08-30 2002-10-01 Novo Nordisk A/S Derivatives of GLP-1 analogs
US6384016B1 (en) 1998-03-13 2002-05-07 Novo Nordisk A/S Stabilized aqueous peptide solutions
US6268343B1 (en) 1996-08-30 2001-07-31 Novo Nordisk A/S Derivatives of GLP-1 analogs
WO1998024464A1 (en) 1996-12-03 1998-06-11 Trustees Of Boston University Specific antagonists for glucose-dependent insulinotropic polypeptide (gip)
US6004297A (en) 1998-01-30 1999-12-21 Novo Nordisk A/S Injection syringe
EP1056775B1 (en) 1998-02-27 2010-04-28 Novo Nordisk A/S Glp-1 derivatives of glp-1 and exendin with protracted profile of action
JP2002526554A (ja) 1998-10-07 2002-08-20 メディカル カレッジ オブ ジョージア リサーチ インスティチュート，インコーポレイテッド 骨親和性ホルモンとして用いられるグルコース依存性インスリン親和性ペプチド
WO2000034331A2 (en) 1998-12-07 2000-06-15 Societe De Conseils De Recherches Et D'applications Scientifiques Sas Analogues of glp-1
DE60012721D1 (de) 1999-03-29 2004-09-09 Uutech Ltd Analoge des magensaft inhibierenden peptides und ihre verwendung für die behandlung von diabetes
GB0404124D0 (en) * 2004-02-25 2004-03-31 Univ Ulster Antagonists of GIP
US20050272652A1 (en) * 1999-03-29 2005-12-08 Gault Victor A Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesity
HU230603B1 (hu) 2000-12-07 2017-03-28 Eli Lilly And Company GLP1 fúziós fehérjék
US20030232761A1 (en) 2002-03-28 2003-12-18 Hinke Simon A. Novel analogues of glucose-dependent insulinotropic polypeptide
WO2004067548A2 (en) 2003-01-31 2004-08-12 Theratechnologies Inc. Chemically modified metabolites of regulatory peptides and methods of producing and using same
BRPI0606992A2 (pt) 2005-02-11 2009-07-28 Amylin Pharmaceuticals Inc análogo e polipeptìdeos hìbridos de gip com propriedades selecionáveis
US8263545B2 (en) 2005-02-11 2012-09-11 Amylin Pharmaceuticals, Inc. GIP analog and hybrid polypeptides with selectable properties
TWI372629B (en) 2005-03-18 2012-09-21 Novo Nordisk As Acylated glp-1 compounds
EP2004238A2 (en) 2006-03-21 2008-12-24 Amylin Pharmaceuticals, Inc. Peptide-peptidase inhibitor conjugates and methods of using same
CA2660835A1 (en) * 2006-08-17 2008-02-21 Amylin Pharmaceuticals, Inc. Dpp-iv resistant gip hybrid polypeptides with selectable propperties
CN104829706A (zh) 2008-08-07 2015-08-12 益普生制药股份有限公司 糖依赖性胰岛素释放肽的类似物
DK2320923T3 (en) 2008-08-07 2015-03-02 Ipsen Pharma Sas Truncated analogues of glucose-dependent insulinotropic polypeptide
WO2010016936A1 (en) 2008-08-07 2010-02-11 Ipsen Pharma S.A.S. Pharmaceutical compositions of analogues of glucose-dependent insulinotropic polypeptide
EP2323678B1 (en) 2008-08-07 2016-03-23 Ipsen Pharma S.A.S. Glucose-dependent insulinotropic polypeptide analogues
MX2011001032A (es) 2008-08-07 2011-08-12 Ipsen Pharma Sas Analogos polipeptidos de insulinotropicos dependientes de glucosa (gip) modificados en n terminal.
JP2013518115A (ja) 2010-01-27 2013-05-20 インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーション 代謝疾患及び肥満の治療のためのグルカゴンアンタゴニスト‐ｇｉｐアゴニスト複合体及び組成物
US9023986B2 (en) 2010-10-25 2015-05-05 Hoffmann-La Roche Inc. Glucose-dependent insulinotropic peptide analogs
MX2013007327A (es) * 2010-12-22 2014-01-08 Marcadia Biotech Inc Metodos para tratar transtornos metabolicos y obesidad con peptidos basados en glucagon activos para el receptor de gip y glp-1.
JP5914641B2 (ja) * 2011-06-10 2016-05-11 ベイジン・ハンミ・ファーマシューティカル・カンパニー・リミテッドＢｅｉｊｉｎｇ Ｈａｎｍｉ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｃｏ．， Ｌｔｄ． グルコース依存性インスリン分泌刺激ポリペプチドのアナログ、医薬組成物及びその使用
US20140377171A1 (en) * 2011-06-10 2014-12-25 Jean Claude Reubi Imaging and Treatment of Neuroendocrine Tumors with Glucose - Dependent Insulinotropic Polypeptide or Analogues or Antagonists Thereof
US20160058881A1 (en) * 2013-03-15 2016-03-03 Indiana University Research And Technology Corporation Prodrugs with prolonged action
EP3189072B1 (en) * 2014-09-05 2018-07-18 University of Copenhagen Gip peptide analogues
EP3985016A1 (en) * 2014-10-29 2022-04-20 Zealand Pharma A/S Gip agonist compounds and methods
EP3310376A4 (en) 2015-06-17 2019-01-23 The California Institute for Biomedical Research MODIFIED THERAPEUTIC AGENTS AND COMPOSITIONS THEREOF
WO2018069442A1 (en) * 2016-10-12 2018-04-19 University Of Copenhagen Peptide dual agonists of gipr and glp2r
EP3569248B1 (en) 2016-12-26 2023-12-06 Kao Corporation Gip inhibitors for improving cognitive function
JP7165495B2 (ja) 2016-12-26 2022-11-04 花王株式会社 運動調節機能向上剤
CN110099694A (zh) 2016-12-26 2019-08-06 花王株式会社 低体温改善剂
CA3064510A1 (en) 2017-05-31 2018-12-06 University Of Copenhagen Long-acting gip peptide analogues

Also Published As

Publication number Publication date
KR20200014287A (ko) 2020-02-10
US11572399B2 (en) 2023-02-07
US20200087373A1 (en) 2020-03-19
EP3630806A1 (en) 2020-04-08
EP4361173A3 (en) 2024-07-03
BR112019025195A8 (pt) 2020-07-07
ES2972848T3 (es) 2024-06-17
AU2018276434A1 (en) 2020-01-02
CN110691788A (zh) 2020-01-14
EP4361173A2 (en) 2024-05-01
CN110691788B (zh) 2024-05-31
BR112019025195A2 (pt) 2020-06-23
AU2018276434B2 (en) 2021-12-16
JP2020521784A (ja) 2020-07-27
CA3064510A1 (en) 2018-12-06
EP3630806B1 (en) 2024-01-10
WO2018220123A1 (en) 2018-12-06

Similar Documents

Publication Publication Date Title
IL269581A (en) GIP receptor activating peptide
IL283385A (en) Different analogs of gip peptide
ZA201901253B (en) Amylin analogues
HUE061271T2 (hu) Mitokondriumokat célzó peptidek
IL253924A0 (en) Amylin analogs
IL275129A (en) New spirobicyclic analogs
PL3630806T3 (pl) Analogi peptydów gip o długotrwałym działaniu
IL277483A (en) New anti-GLP-1 analogs
SG11201912812RA (en) Scrubber
HK1254601A1 (zh) 新型肽
ZA202000215B (en) Long-acting formulations
EP3645031A4 (en) PEPTIDIC ANALOGUES
PL3189072T3 (pl) Analogi peptydowe gip
SG11202005653RA (en) Novel peptide
EP3710462A4 (en) BRARTEMICIN ANALOGA
GB201506316D0 (en) Novel peptide
EP3400237A4 (en) PEPTIDE ANALOGS
GB201406581D0 (en) PAP Peptide analogues
IL257803B (en) Peptide analogs derived from vdac1
EP3906225C0 (en) PANTOTHENAMIDE ANALOGUES
EP3649130C0 (en) SERUM-STABLE PROCOELENTERAZINE ANALOGUE
GB201719520D0 (en) Neuroprotectvie peptide
GB201715378D0 (en) Peptides
GB201715379D0 (en) Peptides
GB201711620D0 (en) Peptides